Literature DB >> 11041220

Endothelial cell dysfunction following prolonged activation of progesterone receptor.

J C Rodríguez-Manzaneque1, M Graubert, M L Iruela-Arispe.   

Abstract

Progestin-only contraceptives are associated with breakthrough bleeding in up to 50% of users. The causes of blood vessel rupture are not well understood. Here we report that both normal and Norplant-exposed endothelium express progesterone receptor. Experiments performed in vitro on endothelial cells isolated from human endometrium revealed that longterm progesterone exposure leads to suppression of endothelial cell proliferation, inhibition of migration and alteration in the profile of extracellular matrix proteins secreted by human endometrial endothelial cells. In addition, we detected increased levels of matrix metalloproteinase-9 in endothelial cultures treated with progesterone. The effect of progesterone on the cell cycle, along with the increased amounts of matrix-degrading enzymes, could account for breakdown of basement membrane components, vascular fragility and consequent vessel rupture leading to breakthrough endometrial bleeding.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11041220     DOI: 10.1093/humrep/15.suppl_3.39

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  5 in total

1.  Effects of etonogestrel treatment in the reproductive organs and uterine arteries of nonoophorectomized guinea pigs.

Authors:  Graciela Krikun; C J Booth; L Buchwalder; F Schatz; G Osol; Maurizio Mandala; C J Lockwood
Journal:  Reprod Sci       Date:  2012-01-19       Impact factor: 3.060

2.  Vascular repair after menstruation involves regulation of vascular endothelial growth factor-receptor phosphorylation by sFLT-1.

Authors:  M D Graubert; M A Ortega; B Kessel; J F Mortola; M L Iruela-Arispe
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

3.  Selective suppression of endothelial cytokine production by progesterone receptor.

Authors:  Lauren M Goddard; Amy N Ton; Tõnis Org; Hanna K A Mikkola; M Luisa Iruela-Arispe
Journal:  Vascul Pharmacol       Date:  2013-06-06       Impact factor: 5.773

4.  Thrombospondin-1 suppresses spontaneous tumor growth and inhibits activation of matrix metalloproteinase-9 and mobilization of vascular endothelial growth factor.

Authors:  J C Rodriguez-Manzaneque; T F Lane; M A Ortega; R O Hynes; J Lawler; M L Iruela-Arispe
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-16       Impact factor: 11.205

5.  Calcineurin activity is required for cardiac remodelling in pregnancy.

Authors:  Eunhee Chung; Fan Yeung; Leslie A Leinwand
Journal:  Cardiovasc Res       Date:  2013-08-28       Impact factor: 10.787

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.